Tratamiento con aripiprazol en la práctica clínica: consenso de un panel de expertos

Translated title of the contribution: Treatment with aripiprazole in clinical practice: Expert consensus panel

Antoni Benabarre, Juan Antonio Campos, Felicia Russo, Giancarlo Cerveri, Davide Prestia, Sergio González, Agustín Pérez-Sendino, Luis Gutiérrez-Rojas

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: To review the scientific evidence on the clinical management of aripiprazole. Methodology: A seven-member expert panel discussed a series of clinical cases. When a consensus was reached, they drew their conclusion. They also reviewed, and included data and clinical evidence from the most relevant aripiprazole clinical trials from the last 10 years. Results: Oral aripiprazole is effective for the treatment of patients with schizophrenia and bipolar disorder, both in the acute and maintenance phase. It was also shown to be effective to prevent relapses. Intramuscular administration is useful in the management of agitation in these patients. The presentation of prolonged action has had positive results in the delay of a relapse in schizophrenic and bipolar patients, and improves treatment compliance. Aripiprazole is a well-tolerated drug and the secondary effects, such as drowsiness, increase in weight, metabolic disorders, or cardiovascular events are less common than in other antipsychotic drugs. Aripiprazole has been well-tolerated when it was used in combination with other antipsychotic drugs, due to their limited interaction. Conclusions: The data from the reviews studied and the consensus of the Expert Panel showed that Aripiprazole is an effective and well-tolerated treatment for patients with schizophrenia, schizo-affective disorders, moderate to severe bipolar disorder, and manic episodes. Its use leads to improved adherence. The lower sedation frequency and the fact that it does affect the cognitive function of the patient improves adherence and places aripiprazole in a good position as a therapeutic option.

Translated title of the contributionTreatment with aripiprazole in clinical practice: Expert consensus panel
Original languageSpanish
JournalPsiquiatria Biologica
DOIs
Publication statusAccepted/In press - Jan 1 2018
Externally publishedYes

Keywords

  • Adherence
  • Aripiprazole
  • Bipolar disorder
  • Manic episodes
  • Third generation antipsychotics

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Treatment with aripiprazole in clinical practice: Expert consensus panel'. Together they form a unique fingerprint.

Cite this